2Anmet L,Materne R,Danse E,et al.Hepatic flow parameters measured with MR imaging and Doppler US:correlations with degree of cirrhosis and portal hypertension[J].Radiology,2003,229(2):409-414.
3Gaiani S,Gramantieri L,Venturoli N,et al.What is the criterion for differentiating chronic hepatitis from compensated cirrhosis?A prospective study comparing ultrasonography and percutaneous liver biopsy[J].J Hepatol,1997,27(6):979-985.
7Friedman SL. Liver fibrosis -- from bench to bedside. J Hepatol2003; 38 Suppl 1:S38-S53.
8Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328:1828-1835.
9Parsons CJ, Bradford BU, Pan CQ, Cheung E, Schauer M, Knorr A, Krebs B, Kraft S, Zahn S, Brocks B, Feirt N, Mei B, Cho MS, Ramamoorthi R, Roldan G, Ng P, Lum P, Hirth-Dietrich C,Tomkinson A, Brenner DA. Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats. Hepatology 2004; 40: 1106-1115.
10Lewindon PJ, Pereira TN, Hoskins AC, Bridle KR, Williamson RM, Shepherd RW, Ramm GA. The role of hepatic stellate cells and transforming growth factor-beta(I) in cystic fibrosis liver disease. Am J Patho12002; 160:1705-1715.
